Page History

...

This example Trial Sets dataset shows information about the test conditions for set A1 and A2 in this example study. Sets A1 and A2 can be seen in the first and second rows respectively of the sample report Table 1 (above). For brevity, the TX dataset and the findings (GT) dataset do not show information for any other sets. Fully formed datasets for this example study would include information about the test conditions and findings for all sets.

Jira

showSummary	false
server	Issue Tracker (JIRA)
serverId	85506ce4-3cb3-3d91-85ee-f633aaaf4a45
key	TOBA-457

Dataset wrap

Name	tx

Rowcaps

Rows 1-17:	Show the experimental parameters that are common for table 1 of study 123.
Rows 18, 25:	Show that sets A1 and A2 each have a parent set code of A. As a child of set A, each of these sets inherit the test conditions of set A.
Rows 18-24:	Show trial set parameters and values that comprise the test conditions for trial set A1. Set A1 is the data for the negative control (concentration 0) with short-term exposure and metabolic activation S9. The applicant has chosen to given a long name (SET) equal to "ST+S9_C0". Set A1 is associated with the first row in the sample report table for study 123.
Rows 25-31:	Show trial set parameters and values that comprise the test conditions for trial set A2. Set A2 is the data for the short-term exposure with metabolic activation S9 at a concentration of 1250 ug/ml. The applicant has chosen to give the set a long name (SET) equal to "ST+S9_C1250". Set A2 is associated with the second row in the sample report table for study 123.

Dataset2

Row	STUDYID	GNTXAID	DOMAIN	SETCD	SET	TXSEQ	TXPARMCD	TXPARM	TXVAL
1	123	MNvit	TX	A	ST+S9	1	METACT	Metabolic Activation	+S9
2	123	MNvit	TX	A	ST+S9	2	METACTFL	Y/N presence of metabolic activation	Y
3	123	MNvit	TX	A	ST+S9	3	TRTDMIN	In vitro Treatment Duration Minimum	3
4	123	MNvit	TX	A	ST+S9	4	TRTDTRG	In vitro Treatment Duration Target	3.5
5	123	MNvit	TX	A	ST+S9	5	TRTDMAX	In vitro Treatment Duration Maximum	4
6	123	MNvit	TX	A	ST+S9	6	TRTDU	In vitro Treatment Duration Unit	HOURS
7	123	MNvit	TX	A	ST+S9	7	RCVDMIN	Recovery Duration Minimum	23.5
8	123	MNvit	TX	A	ST+S9	8	RCVDTRG	Recovery Duration Target	24
9	123	MNvit	TX	A	ST+S9	9	RCVDMAX	Recovery Duration Maximum	24.5
10	123	MNvit	TX	A	ST+S9	10	RCVDU	Recovery Duration Unit	HOURS
11	123	MNvit	TX	A	ST+S9	11	INCBTMP	Incubation Temperature	37
12	123	MNvit	TX	A	ST+S9	12	INCBTMPU	Incubation Temperature Unit	C
13	123	MNvit	TX	A	ST+S9	13	HUMID	Atmospheric Relative Humidity Percent	50
14	123	MNvit	TX	A	ST+S9	14	ATMCO2	Atmospheric CO2 Percent	5
15	123	MNvit	TX	A	ST+S9	15	SPTOBID	Applicant-defined tobacco identifier	CIG01a
16	123	MNvit	TX	A	ST+S9	16	EXPTYP	Exposure Type	Submerged
17	123	MNvit	TX	A	ST+S9	17	SAMTYP	Sample Type	Total Particulate Matter in DMSO
18	123	MNvit	TX	A1	ST+S9_C0	1	PSETCD	Parent Set Code	A
19	123	MNvit	TX	A1	ST+S9_CO	2	INTRVN	Name of the Intervention Article	Tobacco ProdA
20	123	MNvit	TX	A1	ST+S9_C0	3	ITVTYPE	type of intervention article	Negative Control
21	123	MNvit	TX	A1	ST+S9_C0	4	ITVCONC	Concentration of intervention article	0
22	123	MNvit	TX	A1	ST+S9_C0	5	ITVCONCU	Concentration Unit	ug/ml
23	123	MNvit	TX	A1	ST+S9_C0	6	SPDEVID	Applicant-defined device identifier	PUFFMASTER3K
24	123	MNvit	TX	A1	ST+S9_C0	7	DUREFID	Smoke Regimen	Medium Intensity Regimen
25	123	MNvit	TX	A2	ST+S9_C1250	1	PSETCD	Parent Set Code	A
26	123	MNvit	TX	A2	ST+S9_C1250	2	INTRVN	Name of the Intervention Article	Tobacco ProdA
27	123	MNvit	TX	A2	ST+S9_C1250	3	ITVTYPE	type of intervention article	Product
28	123	MNvit	TX	A2	ST+S9_C1250	4	ITVCONC	Concentration of intervention article	1250
29	123	MNvit	TX	A2	ST+S9_C1250	5	ITVCONCU	Concentration Unit	ug/ml
30	123	MNvit	TX	A2	ST+S9_C1250	6	SPDEVID	Applicant-defined device identifier	PUFFMASTER2023
31	123	MNvit	TX	A2	ST+S9_C1250	7	DUREFID	Smoke Regimen	High Intensity Regimen

...

Page tree

Versions Compared

Old Version 135

New Version 136

Key